Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase (TRK) fusion cancer Meeting Abstract
| Authors: | Brose, M. S.; Shen, L.; Tan, D. S. W.; Kummar, S.; Lin, J. J.; McDermott, R.; Berlin, J.; Tahara, M.; Lassen, U. N.; Leyvraz, S.; Patel, J. D.; Norenberg, R.; Dima, L.; Brega, N.; Hong, D. S.; Drilon, A. |
| Abstract Title: | Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase (TRK) fusion cancer |
| Meeting Title: | ESMO Congress 2021 |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2021 Sep 16-21 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-09-01 |
| Start Page: | S600 |
| End Page: | S601 |
| Language: | English |
| ACCESSION: | WOS:000700527701001 |
| DOI: | 10.1016/j.annonc.2021.08.1057 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 535P -- Source: Wos |
